Biogen (BIIB) Return on Sales (2009 - 2026)

Biogen (BIIB) has reported Return on Sales for 18 consecutive years, with 0.0% the latest figure, recorded in Q1 2026.

• In Q1 2026, Return on Sales changed 0.0% year-over-year to 0.0%; the TTM figure through Mar 2026 stood at 0.0% (changed 0.0% YoY), while the FY2025 annual figure was 0.0%, changed 0.0% from the prior year.
• Return on Sales came in at 0.0% for Q1 2026 at Biogen, up from 0.0% in the prior quarter.
• The five-year high for Return on Sales was 0.0% in Q3 2022, with the low at 0.0% in Q3 2023.
• Average Return on Sales over 5 years is 0.0%, with a median of 0.0% recorded in 2024.
• The largest YoY upside for Return on Sales was 0 bps in 2022 against a maximum downside of 0 bps in 2022.
• Year by year, Return on Sales stood at 0.0% in 2022, then tumbled by 52 bps to 0.0% in 2023, then rose by 4 bps to 0.0% in 2024, then slumped by 120 bps to 0.0% in 2025, then surged by 701 bps to 0.0% in 2026.
• According to Business Quant data, Return on Sales over the past three periods registered 0.0%, 0.0%, and 0.0% for Q1 2026, Q4 2025, and Q3 2025 respectively.